The largest insider transaction on today’s list is a Form 4 filing by Artal Group, which reported a purchase of roughly $40.4 million in Lexicon Pharmaceuticals $LXRX.
Artal Group now owns 83,835,950 LXRX shares, representing a roughly 47.5% ownership stake.